GAVIR contains ganciclovir, a nucleoside analogue antiviral medication that inhibits viral DNA synthesis. Once inside infected cells, the drug is converted into its active triphosphate form, which blocks viral DNA polymerase and prevents the virus from replicating.
The medication demonstrates strong activity against:
Ganciclovir is one of the most widely studied treatments for CMV infection. Clinical trials have demonstrated its effectiveness in transplant recipients and patients with HIV.
Studies have shown:
Due to its proven efficacy, ganciclovir is widely used in international clinical practice.
The medication is used to treat and prevent infections caused by cytomegalovirus and other herpes-family viruses.
Main indications include:
The drug works by inhibiting viral DNA synthesis and preventing viral replication.
The medication should be taken orally as prescribed by a healthcare professional. The dosage and duration of therapy depend on the type of infection, immune status of the patient, and clinical response to treatment. Capsules are usually taken with food and sufficient water. Dosage adjustments should only be made by a physician.
Contraindications
Side effects
